1. Home
  2. NOTV vs BRLS Comparison

NOTV vs BRLS Comparison

Compare NOTV & BRLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NOTV
  • BRLS
  • Stock Information
  • Founded
  • NOTV 1974
  • BRLS 2019
  • Country
  • NOTV United States
  • BRLS Canada
  • Employees
  • NOTV N/A
  • BRLS N/A
  • Industry
  • NOTV Biotechnology: Pharmaceutical Preparations
  • BRLS
  • Sector
  • NOTV Health Care
  • BRLS
  • Exchange
  • NOTV Nasdaq
  • BRLS NYSE
  • Market Cap
  • NOTV 137.5M
  • BRLS 126.8M
  • IPO Year
  • NOTV 1997
  • BRLS N/A
  • Fundamental
  • Price
  • NOTV $2.41
  • BRLS $6.48
  • Analyst Decision
  • NOTV Strong Buy
  • BRLS
  • Analyst Count
  • NOTV 3
  • BRLS 0
  • Target Price
  • NOTV $5.92
  • BRLS N/A
  • AVG Volume (30 Days)
  • NOTV 545.2K
  • BRLS 3.9K
  • Earning Date
  • NOTV 05-09-2025
  • BRLS 05-20-2025
  • Dividend Yield
  • NOTV N/A
  • BRLS N/A
  • EPS Growth
  • NOTV N/A
  • BRLS N/A
  • EPS
  • NOTV N/A
  • BRLS N/A
  • Revenue
  • NOTV $475,114,000.00
  • BRLS $28,366,370.00
  • Revenue This Year
  • NOTV $6.37
  • BRLS N/A
  • Revenue Next Year
  • NOTV $5.74
  • BRLS N/A
  • P/E Ratio
  • NOTV N/A
  • BRLS N/A
  • Revenue Growth
  • NOTV N/A
  • BRLS N/A
  • 52 Week Low
  • NOTV $1.23
  • BRLS $3.71
  • 52 Week High
  • NOTV $10.19
  • BRLS $10.75
  • Technical
  • Relative Strength Index (RSI)
  • NOTV 40.48
  • BRLS 56.84
  • Support Level
  • NOTV $1.98
  • BRLS $5.81
  • Resistance Level
  • NOTV $3.35
  • BRLS $6.90
  • Average True Range (ATR)
  • NOTV 0.31
  • BRLS 0.44
  • MACD
  • NOTV -0.02
  • BRLS 0.04
  • Stochastic Oscillator
  • NOTV 31.39
  • BRLS 59.29

About NOTV Inotiv Inc.

Inotiv Inc is a pharmaceutical development company specializing in nonclinical and analytical drug discovery, development services to the pharmaceutical, chemical, and medical device industries. It operates in two segments; Discovery and Safety Assessment (DSA) and Research Models and Services (RMS). Through the DSA segment, the company supports the discovery, nonclinical development, and clinical development needs of researchers and clinicians for small molecule drug candidates, biotherapeutics, and biomedical devices. Through the RMS segment, the company offers access to a wide range of small and large research models for basic research, drug discovery, development, and specialized models for specific diseases and therapeutic areas. The company earns maximum revenue from RMS Segment.

About BRLS BOREALIS FOODS INC

Borealis Foods Inc is a food technology company that has developed high-quality, affordable, sustainable, and nutritious ready-to-eat meals. It is a mission-driven company committed to utilizing its products to help solve national and global food security and nutrition challenges. Its commitment to nutrition, affordability, and sustainability reflects its goal of positively impacting both human life and the planet. Through the development and launch of its ready-made ramen, featuring 20 grams of complete plant-based protein per serving, Borealis is developing advanced solutions to address global food challenges.

Share on Social Networks: